| Literature DB >> 32970938 |
Arash Poursheikhani1,2, Mohammad Reza Abbaszadegan1,2,3, Mohammad Amin Kerachian1,2,4.
Abstract
Colorectal cancer (CRC) is one of the most common cancers globally. Although a variety of CRC screening methods have been developed, many patients are diagnosed at advanced stages of CRC with tumor invasion and distance metastasis. Several studies have suggested the long noncoding RNAs (lncRNAs) as one of the main contributors in CRC tumorigenesis, although the exact underlying mechanism of lncRNAs in CRC is still unknown. Numerous studies have indicated aberrant expression of lncRNAs in CRC through different modes of action such as cell proliferation, apoptosis, cell cycle, DNA repair response, drug-resistance, migration, and metastasis. Furthermore, lncRNA polymorphisms can influence the risk of CRC development. Accordingly, lncRNAs can be served as promising diagnostic or prognostic biomarkers and also desired therapeutic targets affecting the outcome of patients with CRC. In this review, we summarized the updated and novel evidence that identifies different roles of lncRNAs in the tumorigenesis of CRC.Entities:
Keywords: colon adenocarcinoma; colorectal cancer; epigenetic; long noncoding RNAs; microRNA
Mesh:
Substances:
Year: 2020 PMID: 32970938 DOI: 10.1111/ajco.13452
Source DB: PubMed Journal: Asia Pac J Clin Oncol ISSN: 1743-7555 Impact factor: 2.601